Breaking News on Global Pharmaceutical Technology & Manufacturing

Top Headlines

Dr Reddy’s Q1: warning letter ‘significantly impacted our earnings’

US FDA warnings and Venezuela's economic crisis have contributed to “a challenging quarter” for Dr Reddy’s, with its API business being particularly affected.

Cambrex predicts flat generic API sales for 2016

Cambrex to start work on Pharma 4 API site in 2016

Cambrex has said it will invest around $20m in its Pharma 4 API facility before the end of the year in an effort to get ahead of the capacity utilisation curve.

Amgen begins to see results from manufacturing efficiency drive

A restructuring programme which closed two US facilities and slashed hundreds of jobs has paid off says Amgen, attributing increased margins to better manufacturing efficiencies.

Scientists at ex AstraZeneca site join Obama’s $350m antibiotic effort

Scientists at AstraZeneca’s former R&D site in Alderley Park will play a key role in researching antibiotics and the spread of resistance under an initiative launched by US President Barack Obama.

GSK commits to UK manufacturing with £275m investments across three sites

GSK will pump £275m ($360m) into its UK manufacturing network and says the country has a “leading position in life sciences” despite the recent Brexit vote.

BASF reports lower demand for remaining APIs in Q2

BASF has said it saw lower demand for its remaining APIs in the second quarter.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...